{"id":"https://openalex.org/W4404064818","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","title":"1162 An update on immune checkpoint inhibitor-induced diabetes mellitus across NCI trials","display_name":"1162 An update on immune checkpoint inhibitor-induced diabetes mellitus across NCI trials","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404064818","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1162"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2024-sitc2024.1162","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022032234","display_name":"Zoe Quandt","orcid":"https://orcid.org/0000-0002-4568-4368","observed_orcids":["https://orcid.org/0000-0002-4568-4368"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zoe Quandt","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077629580","display_name":"Shanda R. Finnigan","orcid":"https://orcid.org/0000-0002-0555-8965","observed_orcids":["https://orcid.org/0000-0002-0555-8965"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shanda Finnigan","raw_affiliation_strings":["National Cancer Institute, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064511804","display_name":"Vanessa Hill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154570441","display_name":"University of California, Santa Barbara","ror":"https://ror.org/02t274463","country_code":"US","type":"education","lineage":["https://openalex.org/I154570441"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vanessa Hill","raw_affiliation_strings":["University of California, Santa Barbara, Santa Barbara, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Santa Barbara, Santa Barbara, CA, USA","institution_ids":["https://openalex.org/I154570441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069888959","display_name":"Joe Dib","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joe Dib","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074998896","display_name":"Jason Burian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I66946132","display_name":"University of Maryland, College Park","ror":"https://ror.org/047s2c258","country_code":"US","type":"education","lineage":["https://openalex.org/I66946132"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Burian","raw_affiliation_strings":["University of Maryland, College Park, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, College Park, MD, USA","institution_ids":["https://openalex.org/I66946132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067026302","display_name":"Sapir Tessler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I66946132","display_name":"University of Maryland, College Park","ror":"https://ror.org/047s2c258","country_code":"US","type":"education","lineage":["https://openalex.org/I66946132"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sapir Tessler","raw_affiliation_strings":["University of Maryland, College Park, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, College Park, MD, USA","institution_ids":["https://openalex.org/I66946132"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Darah Davidson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I66946132","display_name":"University of Maryland, College Park","ror":"https://ror.org/047s2c258","country_code":"US","type":"education","lineage":["https://openalex.org/I66946132"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darah Davidson","raw_affiliation_strings":["University of Maryland, College Park, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, College Park, MD, USA","institution_ids":["https://openalex.org/I66946132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090621600","display_name":"Abdul Rafeh Naqash","orcid":"https://orcid.org/0000-0001-7622-720X","observed_orcids":["https://orcid.org/0000-0001-7622-720X"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdul Rafeh Naqash","raw_affiliation_strings":["Stephenson Cancer Center, Oklahoma University, Greenville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Cancer Center, Oklahoma University, Greenville, NC, USA","institution_ids":["https://openalex.org/I4390039380"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Anderson","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028772063","display_name":"Megan K. D. Othus","orcid":"https://orcid.org/0000-0001-8176-6371","observed_orcids":["https://orcid.org/0000-0001-8176-6371"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Othus","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022594161","display_name":"Elad Sharon","orcid":"https://orcid.org/0000-0002-0044-9719","observed_orcids":["https://orcid.org/0000-0002-0044-9719"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elad Sharon","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA","National Cancer Institute, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"National Cancer Institute, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1286","last_page":"A1286"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/ctla-4-inhibitors","display_name":"CTLA-4 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7020000219345093},{"id":"https://openalex.org/keywords/diabetic-ketoacidosis","display_name":"diabetic ketoacidosis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/steroid-induced-diabetes-mellitus","display_name":"steroid-induced diabetes mellitus","score":0.703000009059906},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.6769999861717224},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7540000081062317},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.5759999752044678},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5775395631790161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4308008551597595},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.35862764716148376},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.10821598768234253}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2024-sitc2024.1162","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2024-sitc2024.1162","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1162","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281791857","https://openalex.org/W2896438236","https://openalex.org/W7117300816","https://openalex.org/W3119919857","https://openalex.org/W4391822925","https://openalex.org/W4388042379","https://openalex.org/W3034406582","https://openalex.org/W3023939466","https://openalex.org/W2969953401","https://openalex.org/W4388070855"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3,123,319],"(CPI)":[4],"are":[5],"known":[6],"to":[7,33,89,129,140,245,258,314,329,370],"cause":[8],"new-onset":[9],"diabetes":[10,90,104,147,246],"(CPI-DM).":[11],"While":[12,295],"rare,":[13],"this":[14,415,433],"adverse":[15,44,81],"event":[16,45],"can":[17],"be":[18],"challenging":[19],"for":[20,86,335,403,414,421,432],"clinicians":[21],"and":[22,37,59,103,136,238,317,373,385],"negatively":[23],"impact":[24],"patient":[25],"quality":[26],"of":[27,40,54,80,171,195,211,253,262,277,337,342],"life.":[28],"Therefore,":[29],"it":[30],"is":[31],"important":[32],"identify":[34],"risk":[35],"factors":[36],"clinical":[38,63],"characteristics":[39],"the":[41,67,268,286],"immune":[42],"related":[43,88],"(irAE).":[46],"We":[47],"present":[48],"an":[49,183,274,345],"expanded":[50],"comprehensive,":[51],"multi-institutional":[52],"study":[53],"CPI-DM":[55,165,263,306,338,355,362],"across":[56],"multiple":[57],"agents":[58,126],"cancer":[60,271,293,381,388],"types":[61,382],"from":[62,127],"trials":[64],"sponsored":[65,353],"by":[66],"National":[68],"Cancer":[69,75],"Institute":[70],"(NCI).":[71],"Methods":[72],"The":[73,260],"NCI":[74,351],"Therapy":[76],"Program":[77],"(CTEP)":[78],"database":[79],"events":[82],"(AEs)":[83],"was":[84,134,166,264,267,288,299,310,333,356,363,401,412,419,430],"queried":[85],"AEs":[87,255],"(grade":[91],"3":[92],"or":[93,118,124,160,179,247],"4":[94],"hyperglycemia,":[95],"acidosis":[96,242],"including":[97],"diabetic":[98],"ketoacidosis":[99],"(DKA),":[100],"glucose":[101],"intolerance":[102],"mellitus)":[105],"among":[106,305],"all":[107],"patients":[108,199,326,368],"who":[109],"had":[110,216,220,224,230,235,241,248],"been":[111],"treated":[112,200],"with":[113,121,157,162,182,201,207,273,281,324,340],"a":[114,357],"PD-(L)1":[115,318,372],"inhibitor":[116,297],"alone":[117],"in":[119,177,290,367,380],"combination":[120,315,371,392],"CTLA-4":[122,316,374],"other":[125],"6/2015":[128],"12/2022.":[130],"Each":[131],"AE":[132],"report":[133],"reviewed":[135],"classified":[137],"as":[138],"due":[139],"CPI":[141,302],"DM,":[142],"new":[143,225],"onset":[144],"type":[145,303],"2":[146],"mellitus":[148],"(T2DM),":[149],"T2DM":[150,226,231],"exacerbation":[151],"without":[152],"medication":[153,158,236],"non-adherence,":[154,237],"existing":[155],"DM":[156],"non-compliance,":[159],"association":[161],"steroids":[163],"(SDM).":[164],"diagnosed":[167],"based":[168],"on":[169],"evidence":[170],"insulin":[172,185],"deficiency":[173],"either":[174],"through":[175],"presentation":[176],"DKA":[178],"low":[180],"c-peptide":[181],"ongoing":[184],"requirement":[186],"and/or":[187],"positive":[188],"islet":[189],"autoantibodies.":[190],"Results":[191],"In":[192],"total,":[193],"out":[194],"just":[196],"over":[197,282],"14,400":[198],"CPIs,":[202],"there":[203],"were":[204,256],"178":[205],"cases":[206,339],"at":[208],"least":[209],"one":[210],"these":[212,254,377],"AEs;":[213],"73":[214],"(0.51%)":[215],"CPI-DM,":[217],"51":[218],"(0.35%)":[219],"SDM,":[221],"5":[222],"(0.03%)":[223],",":[227],"19":[228],"(0.13%)":[229],"exacerbation,":[232],"10":[233],"(0.07%)":[234],"20":[239],"(0.14%)":[240],"not":[243],"attributable":[244,257],"insufficient":[249],"data.":[250],"Overall,":[251],"41%":[252],"CPI-DM.":[259],"incidence":[261,276,287,309],"0.51%.":[265],"Melanoma":[266],"most":[269,300],"frequent":[270,301],"(21/73)":[272],"overall":[275],"1.13%.":[278],"Among":[279,350],"cancers":[280],"100":[283],"subjects":[284],"exposed,":[285],"highest":[289],"renal":[291,386],"cell":[292,387],"(1.41%).":[294],"PD1":[296],"monotherapy":[298],"(40/73)":[304],"patients,":[307],"its":[308],"lower":[311],"(0.38%)":[312],"compared":[313],"(0.96%)":[320],"(chi-square":[321],"p":[322],"<0.01),":[323],"many":[325],"also":[327],"exposed":[328,369],"additional":[330],"agents.":[331],"Hospitalization":[332],"required":[334],"87.5%":[336],"74.3%":[341],"those":[343],"requiring":[344],"inpatient":[346],"endocrine":[347],"consult.":[348],"Conclusions":[349],"CTEP":[352],"trials,":[354],"rare":[358],"but":[359,406,424],"costly":[360],"irAE.":[361],"significantly":[364],"more":[365],"common":[366],"immunotherapy.":[375],"Given":[376],"findings,":[378],"providers":[379],"like":[383],"melanoma":[384],"that":[389],"frequently":[390],"use":[391],"immunotherapy":[393],"may":[394],"need":[395],"increased":[396],"vigilance.":[397],"Ethics":[398],"Approval":[399],"Consent":[400,417,418],"obtained":[402,420],"each":[404,422],"trial":[405,423],"de-identified,":[407,425],"human":[408,426],"subject":[409,427],"exempt":[410,428],"data":[411,429],"used":[413,431],"analysis.":[416,434]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2024-11-06T00:00:00"}